Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says 
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix 
Asian Stocks Slip as Korea’s KOSPI Tumbles Amid Iran Conflict and Chip Sector Profit-Taking 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
South Korea Central Bank Signals Inflation Concerns as Oil Prices Surge 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Tabletop particle accelerator could transform medicine and materials science 
Armani Group Eyes Strategic Stake Sale to Luxury Giants 
Oil Prices Rise as Dollar Gains Ahead of Key U.S. Inflation Data 
Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.
